Evommune, Inc. Common Stock (EVMN)

Cash & Short-Term Investments

$200.79M

Quarterly · Period ending: · USD

EVMN logo

EVMN Cash & Short-Term Investments

Latest reported$149.20M
EVMN FY Cash & Short-Term Investments ($79.08M → $149.20M)
High-resolution chart · PNG

EVMN cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
149,200,000
72,040,000
79,084,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.